Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT01080716Phase 2Completed
A Phase 2 trial of shigella sonnei strain wrss1 vaccine in shigellosis, sponsored by U.S. Army Medical Research and Development Command. Started May 2010; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT01080716.